Clinical Trials in Maryland

Showing 9221-9240 of 23,284 trials

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

NCT03373201

The aim of this study is to investigate tasimelteon vs. placebo on sleep in healthy individuals after a phase advance in jet lag type insomnia.

Jet Lag Type Insomnia

Vanda Pharmaceuticals320 participantsStarted Oct 2017

Little Rock, Arkansas, United States • Alameda, California, United States • San Diego, California, United States +9 more locations

COMPLETEDNA17 miles

Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study)

NCT05319236

Subjects will use the Gabi system on a daily basis for 3 months, each time the subject is resting or asleep. The Gabi system will recording the SpO2, pulse rate, respiratory rate and movements of the subject. The objective of this study is to perform a first assessment of the range of most potentially clinically relevant indications for use of the Gabi system for children \< 6 years old with underlying medical conditions. This is performed by asking HCPs to review the data measured by the Gabi system after taking a medical decision independently from the Gabi data and to assess the potential clinical utility of the Gabi system. The usability of the system will also be assessed throughout questionnaires filled out by the HCPs and by the caregivers. \*During this study, the data collected by the Gabi system are not intended to be used by caregivers or HCPs to take any (medical) decisions.

Cardiac DiseaseRespiratory DiseaseCongenital Cardiac Defect+4 more

Gabi SmartCare101 participantsStarted Feb 2022

Washington D.C., District of Columbia, United States • New York, New York, United States • Antwerp, Belgium +1 more locations

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study)

Find Trials by Condition in Maryland

MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Anti-HIV Medications for People Recently Infected With HIV

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function

Addressing Dementia Via Agitation-Centered Evaluation

Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)

Multi-Center Pilot Study of Cutera truSculpt Device

Study of a Novel Laser for Skin Rejuvenation

Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers

Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis